Cleary Gottlieb and Walder Wyss represented International Flavors & Fragrances in the transaction. Clifford Chance advised Citi. Freshfields has advised LANXESS. International Flavors & Fragrances (IFF)...
Lanxess’ $1.3 Billion Acquisition of IFF’s Microbial Control Business
H&T Presspart’s Acquisition Of novelex AG From Liberta Partners
ARQIS has advised Liberta Partners on the deal. Walder Wyss and Grüter Rechtsanwälte advised H&T Presspart. Liberta Partners sold novelex AG to H&T Presspart, a division...
Triton’s Acquisition of Swiss IT Security Group
Bär & Karrer acted as Lead Counsel to Triton Fund V, alongside with Latham & Watkins LLP (Germany) and Allen & Overy LLP (Netherlands and Belgium)....
Invision’s Acquisition of a Majority Stake in Plumettaz
Niederer Kraft Frey advised Invision on the deal. Walder Wyss advised Evoco AG. Invision, a leading investment company focused on succession solutions and growth financing in...
MKS Instruments’ $4.4 Billion Acquisition of Atotech
Paul Hastings advised J.P. Morgan and Barclays Bank PLC on the deal. Walder Wyss and DLA Piper advised MKS Instruments. MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”),...
ArchiMed’s Acquisition of Stragen Pharma Group
Walder Wyss advised Stragen Pharma and its shareholders in the transaction. Homburger acted as Swiss legal counsel to ArchiMed. Private equity healthcare fund ArchiMed announced the...
Imburse’s $12 million Series A Funding Round
Walder Wyss has advised Imburse on this transaction. Cloud based payments integration platform provider Imburse has announced the completion of a USD 12 million Series A...
Sulzer & Schmid Laboratories AG’s Series B Financing Round
Walder Wyss has advised Swisscanto Invest by Zürcher Kantonalbank on the deal. Sulzer Schmid has completed a series B round. The company achieved significant growth in 2020,...
Sulzer & Schmid Laboratories AG’s Series B Financing Round
Walder Wyss has advised Swisscanto Invest by Zürcher Kantonalbank on the deal. Sulzer Schmid has completed a series B round. The company achieved significant growth in 2020,...
Alentis Therapeutics’ $67 Million Series B Financing Round
Walder Wyss advised Alentis Therapeutics AG on the deal. Alentis Therapeutics AG announced a USD 67m series B financing round. Morningside Venture Investments led the financing, joined...
proLogistik Holding GmbH’s Acquisition of Xelog AG
Walder Wyss advised the proLogistik group on the deal. Kellerhals Carrard advised DRS Investment GmbH. The private investment company DRS Investment GmbH has sold all shares...
Intercity Group Holding AG’s Partnership Agreement with DBS Group
Baker McKenzie advised Intercity Group Holding AG on the deal. Walder Wyss AG acted as legal counsel to DBS Group. Intercity Group Holding AG signed a strategic...